Trial Profile
An Open,Single-centre Pilot Study of Efficacy and Safety of Topical MOB015B in the Treatment of Distal Subungual Onychomycosis (DSO).
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Aug 2016
Price :
$35
*
At a glance
- Drugs Terbinafine (Primary)
- Indications Onychomycosis
- Focus Therapeutic Use
- Sponsors Moberg Pharma
- 17 Sep 2014 Results published in the Media Release.
- 17 Sep 2014 Status changed from active, no longer recruiting to completed.
- 13 May 2014 Positive interim results have been published in the Moberg Pharma media release.